Log In
BCIQ
Print this Print this
 

Regenemab

  Manage Alerts
Collapse Summary General Information
Company Regenesance B.V.
Description mAb against complement C6 (C6)
Molecular Target Complement 6 (C6)
Mechanism of ActionAntibody
Therapeutic ModalityBiologic: Antibody
Latest Stage of DevelopmentPreclinical
Standard IndicationParoxysmal nocturnal hemoglobinuria (PNH)
Indication DetailsTreat paroxysmal nocturnal hemoglobinuria (PNH)
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today